[Beta 2-microglobulin in medical disease].

Area of Science:

• Biochemistry
• Nephrology
• Oncology
• Immunology

Background:

• Beta-2-microglobulin (beta 2M) is a low-molecular weight protein freely filtered by glomeruli and reabsorbed in proximal tubules.
• Renal disease, particularly acute tubulo-interstitial nephropathy, impairs reabsorption, leading to increased urinary beta 2M excretion.
• Reduced glomerular filtration rate elevates serum beta 2M levels.

Purpose of the Study:

• To elucidate the diagnostic and prognostic significance of beta-2-microglobulin (beta 2M) in various clinical conditions.
• To explore the utility of beta 2M measurements in renal disease, malignant disorders, and infectious diseases.

Main Methods:

• Analysis of beta 2M levels in serum, urine, and cerebrospinal fluid (CSF).
• Correlation of beta 2M concentrations with disease states, tumor burden, and treatment response.
• Evaluation of beta 2M in saliva for specific conditions like Sjögren's syndrome.

Main Results:

• Increased urinary beta 2M suggests proximal tubule damage in renal disease.
• Elevated serum beta 2M correlates with tumor mass in malignancies and indicates poor prognosis in HIV.
• Serum beta 2M levels decrease with remission and increase with relapse in certain leukemias and lymphomas.
• CSF beta 2M is valuable for diagnosing CNS involvement in AIDS and lymphomas.

Conclusions:

• Beta-2-microglobulin (beta 2M) serves as a sensitive, albeit non-specific, marker for inflammation and infection.
• Serum and CSF beta 2M levels provide valuable prognostic information in various cancers and HIV.
• Beta 2M determination aids in diagnosing and monitoring conditions ranging from kidney disease to CNS infections and malignancies.